Mauna Kea Technologies today announced 20 abstracts supporting Cellvizio®<\/sup> to be presented at the Digestive Disease Week (DDW) Conference, being held on June 2-5 in Washington, D.C. These abstracts focus on Barrett’s esophagus, Inflammatory Bowel Disease \/ Syndrome (IBD \/ IBS), pancreatic cyst and other gastrointestinal diseases. This year marks a turning point for endomicroscopy with Cellvizio®<\/sup>, as studies are now focused on patient management, the technology having already proven its diagnostic performance in previous years.<\/p>\n “Real-time in vivo optical biopsy with Cellvizio is once again taking center stage at the Digestive Disease Week® as evidenced by the large number of high quality studies presented this year. Endomicroscopy is also been recognized as a key technology for the assessment of pancreatic diseases as Dr Krishna will present in his American Gastroenterological Association invited lecture on CLE.” said Sacha Loiseau, Ph.D., Founder and Chief Executive Officer of Mauna Kea Technologies. “We’re excited to see that most studies focus on demonstrating significant impact on patient management, positioning Cellvizio as a key driver for improved outcomes and reduced healthcare costs in multiple applications such as pancreatic lesions or Inflammatory Bowel Disease, two conditions in great need of better solutions. Our new sales team in the US will surely benefit from this strong momentum.”<\/p>\n A Large Single Center Experience Using EUS-Guided Needle Based Confocal Laser Endomicroscopy For The Management Of Pancreatic Cystic Lesions<\/strong> Needle Based Confocal Laser Endomicroscopy: The Impact On Diagnosis And Management Of Pancreatic Cystic Lesions<\/strong> Confocal Laser Endomicroscopy <\/strong> Food Intolerance In IBS Is Due To An Eosinophil Activation Syndrome?<\/strong> Improving Patient Outcomes With Personalized Inflammatory Bowel Disease Care Using Probe- Based Confocal Laser Endomicroscopy<\/strong> IBS Patients With Reaction To Wheat And Other Food Antigens Proven On Confocal Laser Endomicroscopy (CLE) Have Prognostic Parameters For Disease, Irrespective Of The Antigen They React To<\/strong> Confocal Endomicroscopy (CLE) Based Double Blind Randomized Controlled Cross-Over Study Provides Objective Measurement Of Food Sensitivity In IBS Patients, Their Somatization, Anxiety And Depression<\/strong> <\/p>\nHighlighted Featured Presentations:<\/u><\/h4>\n
\n
\n\tPresentation # 156
\n\tSaturday, June 2; at 2:45 – 3:00 p.m. ET
\n\tRoom 144
\n\tPresenting Author: Somashekar G. Krishna, The Ohio State University Medical Center<\/p>\n<\/li>\n
\n\tPresentation # 184
\n\tSaturday, June 2; at 4:14 – 4:28 p.m. ET
\n\tRoom 144
\n\tPresenting Author: Maxime Palazzo, Ho\u0302pital Beaujon, Clichy, France<\/p>\n<\/li>\n
\n\tPresentation # Sp6
\n\tSaturday, June 2; at 8:22 – 8:44 p.m. ET
\n\tRoom 145B
\n\tPresenting Author: Somashekar G. Krishna, The Ohio State University Medical Center<\/p>\n<\/li>\n
\n\tPresentation # 289
\n\tSunday, June 3; at 11:15 – 11:30 a.m. ET
\n\tHall C
\n\tPresenting Authors: Theresa Pflaum & Annette Fritscher-Ravens, University Hospital Schleswig- Holstein, Kiel, Kiel, Germany<\/p>\n<\/li>\n<\/ul>\nFeatured Poster Session:<\/u><\/h4>\n
\n
\n\tPoster Su1917
\n\tSunday, June 3; at 12:00 – 2:00 p.m. ET
\n\tHall C
\n\tPresenting Authors: Ali M. Ridha & Julia J. Liu, University of Arkansas for Medical Sciences<\/p>\n<\/li>\n
\n\tPoster Mo1050
\n\tMonday, June 4; at 12:00 – 2:00 p.m. ET
\n\tHall C
\n\tPresenting Authors: Marie Moesinger & Annette Fritscher-Ravens, University Hospital Schleswig- Holstein, Kiel, Kiel, Germany<\/p>\n<\/li>\n
\n\tPoster Mo1052
\n\tMonday, June 4; at 12:00 – 2:00 p.m. ET
\n\tHall C
\n\tPresenting Authors: Zino Ruchay & Annette Fritscher-Ravens, University Hospital Schleswig-Holstein, Kiel, Kiel, Germany<\/p>\nYou are also invited to visit us at booth #2145 in the Exhibit Hall.<\/h4>\n<\/li>\n<\/ul>\n